A phase II randomized trial of anastrozole (A) and fulvestrant (F) as consolidation therapy in postmenopausal women with advanced non-small cell lung cancer who have received first-line platinum-based chemotherapy with or without bevacizumab.
B. T. McLaughlin
No relevant relationships to disclose
S. Land
No relevant relationships to disclose
A. A. Tarhini
No relevant relationships to disclose
J. Siegfried
No relevant relationships to disclose
A. Argiris
No relevant relationships to disclose